Antipsychotic medication proven to shrink brain volume

Those clinicians working with psychiatrically disabled people have known about the negative effects of antipsychotic medications used to control more serious negative symptoms. This controlled clinical trial report shows how some antipsychotic medications cause a 10% shrinkage of total brain volume and increased risk of death in children.

These findings have consequences across all aspects of our cognitive, motor and emotional functioning and therefore reinforces the value of trying less invasive methods of treatment before resorting to antipsychotic medication. Neurofeedback, neurotherapies (TDCS, TACS, rTMS) and photobiomodulation are some of the options that should be considered ahead of or in combination with medication to augment medication effects while decreasing severity of side effects. This was shown to work with chemotherapy-induced peripheral neuropathy brain fog in woman undergoing treatment for breast cancer. (Alvarez,2017) 

https://www.madinamerica.com/2020/07/randomized-controlled-trial-confirms-antipsychotics-damage-brain/